MENU
+Compare
HQL
ETF ticker: NYSE
AS OF
Oct 3 closing price
Price
$15.77
Change
+$0.20 (+1.28%)
Net Assets
528.34M

HQL stock forecast, quote, news & analysis

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more

HQL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for HQL with price predictions
Oct 03, 2025

HQL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HQL turned positive on September 26, 2025. Looking at past instances where HQL's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on HQL as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQL advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 221 cases where HQL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HQL broke above its upper Bollinger Band on September 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Industry description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Volume

The average weekly volume growth across all stocks in the abrdn Life Sciences Investors ETF was 14%. For the same stocks of the ETF, the average monthly volume growth was 20% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 68
Price Growth Rating: 52
SMR Rating: 53
Profit Risk Rating: 62
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
HQL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/